Fresenius Medical Care AG & Co. KGaA - Asset Resilience Ratio
Fresenius Medical Care AG & Co. KGaA (FMEA) has an Asset Resilience Ratio of 1.22% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fresenius Medical Care AG & Co. KGaA (FMEA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Fresenius Medical Care AG & Co. KGaA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see FMEA total assets.
Liquid Assets Composition Over Time
This chart breaks down Fresenius Medical Care AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore FMEA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €384.20 Million | 1.22% |
| Total Liquid Assets | €384.20 Million | 1.22% |
Asset Resilience Insights
- Limited Liquidity: Fresenius Medical Care AG & Co. KGaA maintains only 1.22% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Fresenius Medical Care AG & Co. KGaA Industry Peers by Asset Resilience Ratio
Compare Fresenius Medical Care AG & Co. KGaA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC |
Medical Care Facilities | 3.49% |
|
Surgery Partners Inc
NASDAQ:SGRY |
Medical Care Facilities | 0.06% |
|
Chularat Hospital Public Company Limited
BK:CHG |
Medical Care Facilities | 1.18% |
|
Sarana Meditama Metropolitan
JK:SAME |
Medical Care Facilities | 0.00% |
|
Principal Capital Public Company Limited
BK:PRINC |
Medical Care Facilities | 1.23% |
|
Bait Bakfar Ltd
TA:BKFR |
Medical Care Facilities | 8.67% |
|
Regis Healthcare Ltd
AU:REG |
Medical Care Facilities | 2.29% |
|
Oceania Healthcare Ltd
AU:OCA |
Medical Care Facilities | 0.01% |
Annual Asset Resilience Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Fresenius Medical Care AG & Co. KGaA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.77% | €238.77 Million ≈ $279.15 Million |
€31.00 Billion ≈ $36.24 Billion |
-0.11pp |
| 2024-12-31 | 0.88% | €295.63 Million ≈ $345.62 Million |
€33.57 Billion ≈ $39.24 Billion |
+0.48pp |
| 2023-12-31 | 0.40% | €136.29 Million ≈ $159.33 Million |
€33.93 Billion ≈ $39.67 Billion |
-0.07pp |
| 2022-12-31 | 0.48% | €169.98 Million ≈ $198.73 Million |
€35.75 Billion ≈ $41.80 Billion |
+0.08pp |
| 2021-12-31 | 0.40% | €136.36 Million ≈ $159.42 Million |
€34.37 Billion ≈ $40.18 Billion |
-0.11pp |
| 2020-12-31 | 0.51% | €161.69 Million ≈ $189.03 Million |
€31.69 Billion ≈ $37.05 Billion |
+0.11pp |
| 2019-12-31 | 0.40% | €133.32 Million ≈ $155.87 Million |
€32.93 Billion ≈ $38.50 Billion |
+0.03pp |
| 2018-12-31 | 0.38% | €99.59 Million ≈ $116.43 Million |
€26.24 Billion ≈ $30.68 Billion |
+0.37pp |
| 2017-12-31 | 0.01% | €3.48 Million ≈ $4.07 Million |
€24.03 Billion ≈ $28.09 Billion |
-0.97pp |
| 2016-12-31 | 0.98% | €251.32 Million ≈ $293.82 Million |
€25.61 Billion ≈ $29.94 Billion |
-- |
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more